Cancer

Instead of an on-off toggle switch, cancer cells adapt through a series of distinct states of increasing drug resistance.

Scientists have identified a new variant of the cell cycle that could provide insight into how diseases like cancer occur. 

Samples are commonly stored in a way that degrades RNA. Scientists are devising new ways to overcome this obstacle for RNA sequencing. 

In this webinar, Edward Han, Jospeh Zenga, and Tyce Kearl will discuss how optofluidic technologies unlock key immuno-oncology insights for translational applications.

This single test interrogates over 500 genes to profile a patient’s solid tumor, helping to increase the likelihood of identifying an immuno-oncology biomarker or clinically actionable biomarkers that enable targeted therapy options or clinical trial enrollment.

Green algae can be outfitted with nanoparticles, transforming them into efficient drug-delivering machines that target lung tumors.

From normal vertebrate development to tumor cell cannibalism, cell-in-cell events occur in many different contexts across the tree of life

The emergence of innovative analytical methods empowers researchers to comprehensively characterize tumor samples.

A protein in natural killer cells keeps them from turning into more docile counterparts.

Assay Automation Makes Cutting-Edge Research More Accessible to Labs

Irene Ghobrial sequences circulating tumor cells in blood samples to genomically profile patients with multiple myeloma.

Industry expertise helps scientists navigate and streamline antibody-drug conjugate research and development.

Researchers explore the immune system to further understand cancer and illuminate therapy development.

A nutrient-based nanomedicine stopped runaway tumor growth in mice by firing up a latent metabolic pathway.

Epigenetic control of gene expression can switch on genes that push cell division into overdrive independently of genetic faults.

An essential nutrient and the gut flora, thought to have separate but important roles in the immune response, join forces.

In this webinar, Pinaki Bose and Fei Chen will discuss how scientists use spatial biology techniques to study the tumor microenvironment.

Cellular immunogenicity and immunotoxicity assays help scientists design, validate, and translate therapeutic research into treatments that weaponize the immune response against cancer.

Explore a cfDNA library preparation workflow that provides high yield and conversion to improve sensitivity and detection of low variant allele frequencies (VAF).